Screening Novel Vaccine Candidates for Leishmania Donovani by Combining Differential Proteomics and Immunoinformatics Analysis

Visceral leishmaniasis (VL), also known as kala-azar, is the most dangerous form of leishmaniasis. Currently no effective vaccine is available for clinical use. Since the pathogenicity of different Leishmania strains is inconsistent, the differentially expressed proteins in Leishmania strains may pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jianhui, Li, Jiao, Hu, Kaifeng, Zhou, Qi, Chen, Xiaoxiao, He, Jinlei, Yin, Shuangshuang, Chi, Yangjian, Liao, Xuechun, Xiao, Yuying, Qin, Hanxiao, Zheng, Zhiwan, Chen, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260594/
https://www.ncbi.nlm.nih.gov/pubmed/35812381
http://dx.doi.org/10.3389/fimmu.2022.902066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260594/
https://www.ncbi.nlm.nih.gov/pubmed/35812381
http://dx.doi.org/10.3389/fimmu.2022.902066

Ejemplares similares